The pathophysiology underlying the obesity–breast cancer link is complex and multifactorial, involving mechanisms associated with increased circulating insulin and glucose, altered levels of adipokines and estrogen signaling, and chronic inflammation [12,13]. Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.